199 related articles for article (PubMed ID: 18196642)
61. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ
Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655
[TBL] [Abstract][Full Text] [Related]
62. [Pharmacokinetics of beta blockers in hyperthyroidism. Therapeutic relevance].
Bouvier N; Millart H
Therapie; 1998; 53(6):523-31. PubMed ID: 10070229
[TBL] [Abstract][Full Text] [Related]
63. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
Landmark K; Reikvam A
Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
[TBL] [Abstract][Full Text] [Related]
64. Prescribing of beta-blockers after myocardial infarction: a preliminary study of physician motivations and barriers.
Kavookjian J; Mamidi S
Clin Ther; 2008; 30 Pt 2():2241-9. PubMed ID: 19281918
[TBL] [Abstract][Full Text] [Related]
65. Effects of beta-blockers on fracture risk.
Reid IR
J Musculoskelet Neuronal Interact; 2008; 8(2):105-10. PubMed ID: 18622079
[TBL] [Abstract][Full Text] [Related]
66. Beta-blockers for preventing sudden cardiac death.
Giles TD; Basile JN
Postgrad Med; 2003 Dec; 114(6 Suppl Role):30-4. PubMed ID: 19667667
[TBL] [Abstract][Full Text] [Related]
67. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
68. The present status of beta blockers in clinical medicine.
Davies RO; McMahon FG
Ration Drug Ther; 1980 Feb; 14(2):1-8. PubMed ID: 6104847
[No Abstract] [Full Text] [Related]
69. Fifty years of beta-adrenergic blockade: a golden era in clinical medicine and molecular pharmacology.
Frishman WH
Am J Med; 2008 Nov; 121(11):933-4. PubMed ID: 18954835
[No Abstract] [Full Text] [Related]
70. Heart failure roundtable: beta-blockers in the elderly. Introduction.
Califf RM
Postgrad Med; 2002 Dec; 112(6 Suppl Heart):5. PubMed ID: 19667611
[No Abstract] [Full Text] [Related]
71. [Sir James Black, Nobel laureate 1988].
Meijler FL
Ned Tijdschr Geneeskd; 1988 Dec; 132(53):2429-30. PubMed ID: 2905768
[No Abstract] [Full Text] [Related]
72. Beta blockers for peripheral arterial disease.
Paravastu SC; Mendonca DA; da Silva A
Eur J Vasc Endovasc Surg; 2009 Jul; 38(1):66-70. PubMed ID: 19359199
[TBL] [Abstract][Full Text] [Related]
73. Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators.
Lai HM; Aronow WS; Kruger A; Desai H; Amin H; Frishman WH; Cohen M; Sorbera C
Am J Cardiol; 2008 Jul; 102(1):77-8. PubMed ID: 18572039
[TBL] [Abstract][Full Text] [Related]
74. Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
Andersen SS; Hansen ML; Gislason GH; Folke F; Schramm TK; Fosbøl E; Sørensen R; Rasmussen S; Abildstrøm SZ; Madsen M; Køber L; Torp-Pedersen C
Cardiology; 2009; 112(2):144-50. PubMed ID: 18612201
[TBL] [Abstract][Full Text] [Related]
75. [Rational use of blockers of adrenergic receptors].
Vrhovac B
Lijec Vjesn; 1983 Jan; 105(1):49-54. PubMed ID: 6134221
[No Abstract] [Full Text] [Related]
76. Interesting uses of beta blockers: 5 Beta blockers in thyrotoxicosis.
Larkins RG; Heyma P
Aust Fam Physician; 1981 Oct; 10(10):833-5. PubMed ID: 6118114
[No Abstract] [Full Text] [Related]
77. [New aspects of beta-blocker therapy. Pharmacological findings and therapeutic relevance. Satellite symposium of the European cardiology congress in Vienna].
Internist (Berl); 1989 Jan; 30(1 Suppl [NEUE]):1-15. PubMed ID: 2576844
[No Abstract] [Full Text] [Related]
78. [Beta-blockers used as tranquilizers for the examination of nervous states. A questionnaire study among older medical students].
Andreassen KH; Olesen HB; Olsen LH
Ugeskr Laeger; 1985 Nov; 147(46):3734-6. PubMed ID: 2866618
[No Abstract] [Full Text] [Related]
79. Pharmacokinetic optimisation of therapy with beta-adrenergic blocking agents.
Frishman WH; Lazar EJ; Gorodokin G
Clin Pharmacokinet; 1991 Apr; 20(4):311-8. PubMed ID: 1674683
[TBL] [Abstract][Full Text] [Related]
80. [Beta-receptor blockers in ophthalmology].
Demmler N
Med Monatsschr Pharm; 1980 Jun; 3(6):174-9. PubMed ID: 6110166
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
